Skeletal muscle digoxin binding in patients with renal failure

Area of Science:

• Pharmacokinetics
• Nephrology
• Biochemistry

Background:

• Digoxin is a medication used to treat heart conditions.
• Chronic renal failure can affect drug distribution and elimination.
• Understanding digoxin's distribution in tissues is crucial for patients with kidney disease.

Purpose of the Study:

• To investigate skeletal muscle digoxin binding in patients with chronic renal failure.
• To compare muscle-to-serum digoxin concentration ratios in patients with and without renal impairment.

Main Methods:

• Analysis of blood and skeletal muscle samples from digoxin-treated patients with chronic renal failure.
• Comparison with control groups having normal renal function.
• Assessment of the relationship between glomerular filtration rate and muscle digoxin binding.

Main Results:

• No significant difference in skeletal muscle to serum digoxin concentration ratios was observed between patients with chronic renal failure and control groups.
• No correlation was found between glomerular filtration rate and muscle digoxin binding in the renal failure group.

Conclusions:

• Skeletal muscle digoxin binding does not appear to be reduced in patients with chronic renal failure.
• Renal function status does not significantly alter the distribution of digoxin between skeletal muscle and serum.